tiprankstipranks
Trending News
More News >
Staar Surgical (STAA)
NASDAQ:STAA

Staar Surgical (STAA) Stock Statistics & Valuation Metrics

Compare
564 Followers

Total Valuation

Staar Surgical has a market cap or net worth of $919.45M. The enterprise value is $801.93M.
Market Cap$919.45M
Enterprise Value$801.93M

Share Statistics

Staar Surgical has 49,512,750 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding49,512,750
Owned by Insiders
Owned by Institutions

Financial Efficiency

Staar Surgical’s return on equity (ROE) is -0.23 and return on invested capital (ROIC) is -23.05%.
Return on Equity (ROE)-0.23
Return on Assets (ROA)-0.18
Return on Invested Capital (ROIC)-23.05%
Return on Capital Employed (ROCE)-0.24
Revenue Per Employee206.95K
Profits Per Employee-69.53K
Employee Count1,157
Asset Turnover0.53
Inventory Turnover1.03

Valuation Ratios

The current PE Ratio of Staar Surgical is ―. Staar Surgical’s PEG ratio is -0.05.
PE Ratio
PS Ratio4.89
PB Ratio3.40
Price to Fair Value3.40
Price to FCF-34.17
Price to Operating Cash Flow-30.40
PEG Ratio-0.05

Income Statement

In the last 12 months, Staar Surgical had revenue of 239.44M and earned -80.45M in profits. Earnings per share was -1.62.
Revenue239.44M
Gross Profit176.90M
Operating Income-45.87M
Pretax Income-82.26M
Net Income-80.45M
EBITDA-37.18M
Earnings Per Share (EPS)-1.62

Cash Flow

In the last 12 months, operating cash flow was -30.32M and capital expenditures -4.14M, giving a free cash flow of -34.46M billion.
Operating Cash Flow-30.32M
Free Cash Flow-34.46M
Free Cash Flow per Share-0.70

Dividends & Yields

Staar Surgical pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.78
52-Week Price Change3.63%
50-Day Moving Average20.01
200-Day Moving Average22.60
Relative Strength Index (RSI)46.52
Average Volume (3m)1.57M

Important Dates

Staar Surgical upcoming earnings date is May 6, 2026, After Close (Confirmed).
Last Earnings DateMar 3, 2026
Next Earnings DateMay 6, 2026
Ex-Dividend Date

Financial Position

Staar Surgical as a current ratio of 4.55, with Debt / Equity ratio of 11143.17%
Current Ratio4.55
Quick Ratio3.74
Debt to Market Cap0.03
Net Debt to EBITDA1.25
Interest Coverage Ratio0.00

Taxes

In the past 12 months, Staar Surgical has paid -1.81M in taxes.
Income Tax-1.81M
Effective Tax Rate0.02

Enterprise Valuation

Staar Surgical EV to EBITDA ratio is -11.50, with an EV/FCF ratio of -30.82.
EV to Sales4.41
EV to EBITDA-11.50
EV to Free Cash Flow-30.82
EV to Operating Cash Flow-30.82

Balance Sheet

Staar Surgical has $153.15M in cash and marketable securities with $38.35M in debt, giving a net cash position of $114.80M billion.
Cash & Marketable Securities$153.15M
Total Debt$38.35M
Net Cash$114.80M
Net Cash Per Share$2.32
Tangible Book Value Per Share$6.91

Margins

Gross margin is 76.19%, with operating margin of -38.30%, and net profit margin of -33.60%.
Gross Margin76.19%
Operating Margin-38.30%
Pretax Margin-34.36%
Net Profit Margin-33.60%
EBITDA Margin-38.30%
EBIT Margin0.00%

Analyst Forecast

The average price target for Staar Surgical is $20.13, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$20.13
Price Target Upside8.40% Upside
Analyst ConsensusHold
Analyst Count10
Revenue Growth Forecast-32.42%
EPS Growth Forecast-540.37%

Scores

Smart Score1
AI Score